Hereditary Testing

Global Hereditary Testing Market to Reach US$11.8 Billion by 2030

The global market for Hereditary Testing estimated at US$8.2 Billion in the year 2024, is expected to reach US$11.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Preimplantation Genetic Diagnosis & Screening, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Hereditary Testing market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Hereditary Testing Market - Key Trends and Drivers Summarized

Why Is Hereditary Testing Revolutionizing Personalized Medicine?

Hereditary testing has become a transformative tool in modern medicine, enabling the detection of genetic mutations associated with inherited diseases and conditions. It plays a critical role in diagnosing genetic disorders, guiding personalized treatment plans, and informing patients of their potential risk of passing on genetic traits to their offspring. Hereditary testing encompasses a wide range of applications, including cancer risk assessment, reproductive health, and cardiovascular diseases. As the cost of genetic sequencing continues to decrease, hereditary testing has become more accessible, empowering individuals with valuable insights into their health and enabling early intervention or preventive care measures. With advancements in genomic science, hereditary testing is now a cornerstone of personalized medicine, providing tailored healthcare solutions based on individual genetic profiles.

How Are Technological Advancements Expanding the Hereditary Testing Market?

The hereditary testing market has been revolutionized by advancements in genetic sequencing technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR). These technologies allow for faster, more accurate, and cost-effective genetic analysis, making it easier to identify mutations across a broad range of genes. The development of direct-to-consumer (DTC) genetic testing kits has further expanded the market, enabling individuals to access hereditary testing without the need for a healthcare provider. Moreover, the integration of bioinformatics tools and AI has enhanced the ability to interpret complex genetic data, providing deeper insights into gene-environment interactions and hereditary risks. These innovations are also improving the accuracy and reliability of prenatal and preimplantation genetic testing, ensuring safer reproductive health decisions.

How Are Market Segments Shaping the Hereditary Testing Industry?

Test types include predictive testing, carrier testing, prenatal testing, and newborn screening, with predictive testing being the largest segment due to its widespread use in assessing the risk of developing inherited conditions such as cancer. Applications of hereditary testing range from oncology and cardiology to reproductive health and rare genetic disorders. Oncology represents the most significant application, particularly in detecting BRCA1/BRCA2 mutations linked to breast and ovarian cancers. The end-use segment includes hospitals, diagnostic laboratories, and direct-to-consumer testing services, with diagnostic laboratories holding the largest share due to their advanced genetic testing capabilities and infrastructure.

What Factors Are Driving the Growth in the Hereditary Testing Market?

The growth in the hereditary testing market is driven by several factors, including increasing awareness of genetic disorders, technological advancements in genetic sequencing, and the growing demand for personalized medicine. Rising awareness among consumers about the importance of genetic testing for early disease detection and prevention is fueling demand for hereditary testing services. Technological innovations, particularly in next-generation sequencing (NGS), have made hereditary testing faster, more accurate, and affordable, expanding its accessibility to a broader population. The growing focus on personalized healthcare solutions, where treatment plans are tailored based on individual genetic profiles, is further boosting market growth. Additionally, the expansion of direct-to-consumer genetic testing services has democratized access to hereditary testing, allowing individuals to proactively manage their health based on genetic insights.

SCOPE OF STUDY:

The report analyzes the Hereditary Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Test Type (Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening, Other Test Types); Technology (Molecular, Cytogenetic, Biochemical)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• Agilent Technologies, Inc.
• CENTOGENE N.V.
• CooperSurgical, Inc.
• F. Hoffmann-La Roche Ltd
• Fulgent Genetic, Inc.
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings
• Medgenome
• Myriad Genetics, Inc.
• Natera, Inc.
• Quest Diagnostics Incorporated
• Sophia Genetics
• Thermo Fisher Scientific, Inc.
• Twist Bioscience

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.